Effectiveness of a multidrug therapy consisting of ivermectin, azithromycin, montelukast and acetylsalicylic acid to prevent hospitalization and death among ambulatory COVID-19 cases in Tlaxcala, Mexico

{ 'indexed': {'date-parts': [[2024, 3, 29]], 'date-time': '2024-03-29T11:53:54Z', 'timestamp': 1711713234852}, 'reference-count': 49, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2021, 4, 1]], 'date-time': '2021-04-01T00:00:00Z', 'timestamp': 1617235200000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2021, 2, 4]], 'date-time': '2021-02-04T00:00:00Z', 'timestamp': 1612396800000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'http://creativecommons.org/licenses/by-nc-nd/4.0/'}], 'content-domain': { 'domain': [ 'ijidonline.com', 'clinicalkey.jp', 'clinicalkey.com', 'clinicalkey.es', 'clinicalkey.fr', 'clinicalkey.com.au', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2021, 4]]}, 'DOI': '10.1016/j.ijid.2021.02.014', 'type': 'journal-article', 'created': {'date-parts': [[2021, 2, 10]], 'date-time': '2021-02-10T06:58:26Z', 'timestamp': 1612940306000}, 'page': '598-605', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 26, 'title': 'Effectiveness of a multidrug therapy consisting of Ivermectin, Azithromycin, Montelukast, and ' 'Acetylsalicylic acid to prevent hospitalization and death among ambulatory COVID-19 cases in ' 'Tlaxcala, Mexico', 'prefix': '10.1016', 'volume': '105', 'author': [ {'given': 'René', 'family': 'Lima-Morales', 'sequence': 'first', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-5598-5439', 'authenticated-orcid': False, 'given': 'Pablo', 'family': 'Méndez-Hernández', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yvonne N.', 'family': 'Flores', 'sequence': 'additional', 'affiliation': []}, {'given': 'Patricia', 'family': 'Osorno-Romero', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Christian Ronal', 'family': 'Sancho-Hernández', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Elizabeth', 'family': 'Cuecuecha-Rugerio', 'sequence': 'additional', 'affiliation': []}, {'given': 'Adrián', 'family': 'Nava-Zamora', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-4140-455X', 'authenticated-orcid': False, 'given': 'Diego Rolando', 'family': 'Hernández-Galdamez', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Daniela Karola', 'family': 'Romo-Dueñas', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jorge', 'family': 'Salmerón', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'issue': 'September', 'key': '10.1016/j.ijid.2021.02.014_bib0005', 'doi-asserted-by': 'crossref', 'first-page': '104327', 'DOI': '10.1016/j.meegid.2020.104327', 'article-title': 'Recent progress and challenges in drug development against COVID-19 ' 'coronavirus (SARS-CoV-2) — An update on the status', 'volume': '83', 'author': 'Abd El-Aziz', 'year': '2020', 'journal-title': 'Infect Genet Evol'}, { 'issue': 'October', 'key': '10.1016/j.ijid.2021.02.014_bib0010', 'doi-asserted-by': 'crossref', 'first-page': '109883', 'DOI': '10.1016/j.mehy.2020.109883', 'article-title': 'The association between obesity and poor outcome after COVID-19 ' 'indicates a potential therapeutic role for montelukast', 'volume': '143', 'author': 'Almerie', 'year': '2020', 'journal-title': 'Med Hypotheses'}, { 'issue': 'February (8)', 'key': '10.1016/j.ijid.2021.02.014_bib0015', 'doi-asserted-by': 'crossref', 'first-page': '488', 'DOI': '10.1056/NEJM199502233320802', 'article-title': 'The effect of cholesterol-lowering and antioxidant therapy on ' 'endothelium-dependent coronary vasomotion', 'volume': '332', 'author': 'Anderson', 'year': '1995', 'journal-title': 'N Engl J Med'}, { 'issue': 'August', 'key': '10.1016/j.ijid.2021.02.014_bib0020', 'doi-asserted-by': 'crossref', 'first-page': '396', 'DOI': '10.1016/j.ijid.2020.06.099', 'article-title': 'Treatment with Hydroxychloroquine, Azithromycin, and combination in ' 'patients hospitalized with COVID-19', 'volume': '97', 'author': 'Arshad', 'year': '2020', 'journal-title': 'Int J Infect Dis'}, { 'key': '10.1016/j.ijid.2021.02.014_bib0025', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.phrs.2020.105250', 'article-title': 'Meta-analysis on outcome-worsening comorbidities of COVID-19 and ' 'related potential drug-drug interactions', 'author': 'Awortwe', 'year': '2020', 'journal-title': 'Pharmacol Res'}, { 'issue': 'May', 'key': '10.1016/j.ijid.2021.02.014_bib0030', 'article-title': 'COVID-19 treatment in patients with comorbidities: Awareness of ' 'drug–drug interactions', 'author': 'Back', 'year': '2020', 'journal-title': 'Br J Clin Pharmacol'}, { 'issue': 'July (7)', 'key': '10.1016/j.ijid.2021.02.014_bib0035', 'doi-asserted-by': 'crossref', 'first-page': '773', 'DOI': '10.1016/S1473-3099(20)30195-X', 'article-title': 'Real estimates of mortality following COVID-19 infection', 'volume': '20', 'author': 'Baud', 'year': '2020', 'journal-title': 'Lancet Infect Dis'}, { 'issue': 'May', 'key': '10.1016/j.ijid.2021.02.014_bib0040', 'article-title': 'Remdesivir for the treatment of Covid-19—Preliminary report', 'author': 'Beigel', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'issue': 'July', 'key': '10.1016/j.ijid.2021.02.014_bib0045', 'first-page': '1', 'article-title': 'Is acetylsalicylic acid a safe and potentially useful choice for adult ' 'patients with cOVID-19?', 'author': 'Bianconi', 'year': '2020', 'journal-title': 'Drugs'}, { 'issue': 'August (8)', 'key': '10.1016/j.ijid.2021.02.014_bib0050', 'doi-asserted-by': 'crossref', 'first-page': '683', 'DOI': '10.1007/s40261-020-00933-3', 'article-title': 'Azithromycin for COVID-19: More than just an antimicrobial?', 'volume': '40', 'author': 'Bleyzac', 'year': '2020', 'journal-title': 'Clin Drug Investig'}, { 'issue': 'June', 'key': '10.1016/j.ijid.2021.02.014_bib0055', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1080/02770903.2020.1786112', 'article-title': 'Montelukast’s ability to fight COVID-19 infection', 'author': 'Bozek', 'year': '2020', 'journal-title': 'J Asthma'}, { 'issue': 'March', 'key': '10.1016/j.ijid.2021.02.014_bib0060', 'first-page': '1', 'article-title': 'Experimental treatment with favipiravir for COVID-19: An open-label ' 'control study', 'author': 'Cai', 'year': '2020', 'journal-title': 'Engineering (Beijing, China)'}, { 'key': '10.1016/j.ijid.2021.02.014_bib0065', 'doi-asserted-by': 'crossref', 'first-page': '104787', 'DOI': '10.1016/j.antiviral.2020.104787', 'article-title': 'The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 ' 'in vitro', 'volume': '178', 'author': 'Caly', 'year': '2020', 'journal-title': 'Antiviral Res'}, { 'issue': '19', 'key': '10.1016/j.ijid.2021.02.014_bib0070', 'doi-asserted-by': 'crossref', 'first-page': '1787', 'DOI': '10.1056/NEJMoa2001282', 'article-title': 'A trial of lopinavir-ritonavir in adults hospitalized with severe ' 'covid-19', 'volume': '382', 'author': 'Cao', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/j.ijid.2021.02.014_bib0075', 'first-page': '1', 'article-title': 'Safety and efficacy of the combined use of Ivermectin, dexamethasone, ' 'enoxaparin and aspirin against COVID-19', 'author': 'Carvallo', 'year': '2020', 'journal-title': 'medRxiv'}, { 'issue': 'July', 'key': '10.1016/j.ijid.2021.02.014_bib0080', 'article-title': 'Hydroxychloroquine with or without azithromycin in mild-to-moderate ' 'Covid-19', 'author': 'Cavalcanti', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/j.ijid.2021.02.014_bib0085', 'series-title': 'Bases de Datos de Licencias Sanitarias de Insumos para la Salud ' '[Conjunto de Datos]. Documentos', 'author': 'Comisión Federal para la Protección contra Riesgos Sanitarios', 'year': '2016'}, { 'issue': 'August (2)', 'key': '10.1016/j.ijid.2021.02.014_bib0090', 'doi-asserted-by': 'crossref', 'first-page': '201', 'DOI': '10.1002/cpt.1857', 'article-title': 'Clinical pharmacology perspectives on the antiviral activity of ' 'azithromycin and use in COVID-19', 'volume': '108', 'author': 'Damle', 'year': '2020', 'journal-title': 'Clin Pharmacol Ther'}, { 'issue': 'October (17)', 'key': '10.1016/j.ijid.2021.02.014_bib0095', 'first-page': '2184', 'article-title': 'Anti–tumor necrosis factor-α treatment improves endothelial function in ' 'patients with rheumatoid arthritis', 'volume': '106', 'author': 'David', 'year': '2002', 'journal-title': 'Circulation'}, { 'key': '10.1016/j.ijid.2021.02.014_bib0100', 'doi-asserted-by': 'crossref', 'first-page': 'e21', 'DOI': '10.1016/S2213-2600(20)30116-8', 'article-title': 'Are patients with hypertension and diabetes mellitus at increased risk ' 'for COVID-19 infection?', 'volume': '8', 'author': 'Fang', 'year': '2020', 'journal-title': 'Lancet Resp Med'}, { 'issue': 'May (10234)', 'key': '10.1016/j.ijid.2021.02.014_bib0105', 'doi-asserted-by': 'crossref', 'first-page': '1407', 'DOI': '10.1016/S0140-6736(20)30858-8', 'article-title': 'Trials of anti-tumor necrosis factor therapy for COVID-19 are urgently ' 'needed', 'volume': '395', 'author': 'Feldmann', 'year': '2020', 'journal-title': 'Lancet (London, England)'}, { 'issue': 'May', 'key': '10.1016/j.ijid.2021.02.014_bib0110', 'doi-asserted-by': 'crossref', 'first-page': '109828', 'DOI': '10.1016/j.mehy.2020.109828', 'article-title': 'As a potential treatment of COVID-19: Montelukast', 'volume': '142', 'author': 'Fidan', 'year': '2020', 'journal-title': 'Med Hypotheses'}, { 'issue': '17', 'key': '10.1016/j.ijid.2021.02.014_bib0115', 'doi-asserted-by': 'crossref', 'first-page': '2262', 'DOI': '10.1161/CIRCULATIONAHA.107.734384', 'article-title': 'Angiotensin-converting enzyme inhibition improves vascular function in ' 'rheumatoid arthritis', 'volume': '117', 'author': 'Flammer', 'year': '2008', 'journal-title': 'Circulation'}, { 'issue': 'March (1)', 'key': '10.1016/j.ijid.2021.02.014_bib0120', 'doi-asserted-by': 'crossref', 'first-page': '72', 'DOI': '10.5582/bst.2020.01047', 'article-title': 'Breakthrough: Chloroquine phosphate has shown apparent efficacy in ' 'treatment of COVID-19 associated pneumonia in clinical studies', 'volume': '14', 'author': 'Gao', 'year': '2020', 'journal-title': 'Biosci Trends'}, { 'key': '10.1016/j.ijid.2021.02.014_bib0125', 'series-title': 'Datos Abiertos de México — Información Referente a Casos COVID-19 en ' 'México – Bases de Datos COVID-19', 'first-page': '1', 'author': 'Gobierno de México', 'year': '2020'}, { 'issue': 'February (18)', 'key': '10.1016/j.ijid.2021.02.014_bib0130', 'doi-asserted-by': 'crossref', 'first-page': '1708', 'DOI': '10.1056/NEJMoa2002032', 'article-title': 'Clinical characteristics of coronavirus disease 2019 in China', 'volume': '382', 'author': 'Guan', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/j.ijid.2021.02.014_bib0135', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.bjid.2020.06.002', 'article-title': 'Ivermectin: Potential candidate for the treatment of Covid 19', 'author': 'Gupta', 'year': '2020', 'journal-title': 'Braz J Infect Dis'}, { 'issue': 'February (10223)', 'key': '10.1016/j.ijid.2021.02.014_bib0140', 'doi-asserted-by': 'crossref', 'first-page': '497', 'DOI': '10.1016/S0140-6736(20)30183-5', 'article-title': 'Clinical features of patients infected with 2019 novel coronavirus in ' 'Wuhan, China', 'volume': '395', 'author': 'Huang', 'year': '2020', 'journal-title': 'Lancet'}, { 'issue': 'May (10238)', 'key': '10.1016/j.ijid.2021.02.014_bib0145', 'doi-asserted-by': 'crossref', 'first-page': '1695', 'DOI': '10.1016/S0140-6736(20)31042-4', 'article-title': 'Triple combination of interferon beta-1b, lopinavir–2013; ritonavir, ' 'and ribavirin in the treatment of patients admitted to hospital with ' 'COVID-19: An open-label, randomised, phase 2 trial', 'volume': '395', 'author': 'Hung', 'year': '2020', 'journal-title': 'Lancet'}, { 'issue': 'June', 'key': '10.1016/j.ijid.2021.02.014_bib0150', 'doi-asserted-by': 'crossref', 'first-page': '21', 'DOI': '10.22159/ajpcr.2020.v13i8.38357', 'article-title': 'A review on the antiparasitic drug ivermectin for various viral ' 'infections and possibilities of using it for novel Severe Acute ' 'Respiratory Syndrome Coronavirus 2: New hope to treat coronavirus ' 'disease-2019', 'volume': '13', 'author': 'Jabeen', 'year': '2020', 'journal-title': 'Asian J Pharm Clin Res'}, { 'key': '10.1016/j.ijid.2021.02.014_bib0155', 'doi-asserted-by': 'crossref', 'first-page': '1193', 'DOI': '10.12688/f1000research.26707.1', 'article-title': 'The worldwide clinical trial research response to the COVID-19 pandemic ' '— The first 100 days', 'volume': '9', 'author': 'Janiaud', 'year': '2020', 'journal-title': 'F1000Research'}, { 'issue': 'June (3)', 'key': '10.1016/j.ijid.2021.02.014_bib0160', 'doi-asserted-by': 'crossref', 'first-page': '436', 'DOI': '10.1016/j.jmii.2020.03.034', 'article-title': 'Treatment options for COVID-19: The reality and challenges', 'volume': '53', 'author': 'Jean', 'year': '2020', 'journal-title': 'J Microbiol Immunol Infect'}, { 'issue': 'August (2)', 'key': '10.1016/j.ijid.2021.02.014_bib0165', 'article-title': 'SARS-CoV-2 infection-induced immune responses: Friends or foes?', 'volume': '92', 'author': 'Li', 'year': '2020', 'journal-title': 'Scand J Immunol'}, { 'issue': 'October', 'key': '10.1016/j.ijid.2021.02.014_bib0170', 'first-page': '1', 'article-title': 'Understanding severe acute respiratory syndrome coronavirus 2 ' 'replication to design efficient drug combination therapies', 'author': 'Ortega', 'year': '2020', 'journal-title': 'Intervirology'}, { 'key': '10.1016/j.ijid.2021.02.014_bib0175', 'doi-asserted-by': 'crossref', 'first-page': '106053', 'DOI': '10.1016/j.ijantimicag.2020.106053', 'article-title': 'Macrolides and viral infections: Focus on Azithromycin in COVID-19 ' 'pathology', 'volume': '56', 'author': 'Pani', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'issue': 'October', 'key': '10.1016/j.ijid.2021.02.014_bib0180', 'doi-asserted-by': 'crossref', 'first-page': '109721', 'DOI': '10.1016/j.cellsig.2020.109721', 'article-title': 'Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring ' 'promising drugs for the treatment of Covid-19', 'volume': '74', 'author': 'Poduri', 'year': '2020', 'journal-title': 'Cell Signal'}, { 'key': '10.1016/j.ijid.2021.02.014_bib0185', 'article-title': 'Antiviral and anti-inflammatory of Ivermectin and its potential use in ' 'COVID-19', 'author': 'Portmann-Baracco', 'year': '2020', 'journal-title': 'Arch Bronchomeunol'}, { 'issue': 'January', 'key': '10.1016/j.ijid.2021.02.014_bib0190', 'article-title': 'ICON (Ivermectin in COvid Nineteen) study: Use of Ivermectin is ' 'associated with lower mortality in hospitalized patients with COVID19', 'author': 'Rajter', 'year': '2020', 'journal-title': 'medRxiv'}, { 'issue': 'June (24)', 'key': '10.1016/j.ijid.2021.02.014_bib0195', 'doi-asserted-by': 'crossref', 'first-page': '2493', 'DOI': '10.1001/jama.2020.8630', 'article-title': 'Association of treatment with Hydroxychloroquine or Azithromycin with ' 'in-hospital mortality in patients with COVID-19 in New York State', 'volume': '323', 'author': 'Rosenberg', 'year': '2020', 'journal-title': 'JAMA'}, { 'issue': 'April', 'key': '10.1016/j.ijid.2021.02.014_bib0200', 'article-title': 'Pharmacologic treatments for coronavirus disease 2019 (COVID-19): A ' 'review', 'author': 'Sanders', 'year': '2020', 'journal-title': 'JAMA'}, { 'key': '10.1016/j.ijid.2021.02.014_bib0205', 'series-title': 'NORMA Oficial Mexicana NOM-017-SSA2-2012', 'author': 'Secretaría de Salud', 'year': '2013'}, { 'key': '10.1016/j.ijid.2021.02.014_bib0210', 'series-title': 'Lineamiento Estandarizado para la Vigilancia Epidemiológica y por ' 'Laboratorio de la Enfermedad Respiratoria Viral', 'author': 'Secretaría de Salud-Gobierno de México', 'year': '2020'}, { 'issue': 'April (4)', 'key': '10.1016/j.ijid.2021.02.014_bib0215', 'doi-asserted-by': 'crossref', 'first-page': '447', 'DOI': '10.1097/00004872-199816040-00006', 'article-title': 'Effects of angiotensin converting enzyme inhibition on ' 'endothelium-dependent vasodilatation in essential hypertensive patients', 'volume': '16', 'author': 'Taddei', 'year': '1998', 'journal-title': 'J Hypertens'}, { 'issue': 'April (4)', 'key': '10.1016/j.ijid.2021.02.014_bib0220', 'doi-asserted-by': 'crossref', 'first-page': '844', 'DOI': '10.1111/jth.14768', 'article-title': 'Abnormal coagulation parameters are associated with poor prognosis in ' 'patients with novel coronavirus pneumonia', 'volume': '18', 'author': 'Tang', 'year': '2020', 'journal-title': 'J Thromb Haemost'}, { 'issue': 'December', 'key': '10.1016/j.ijid.2021.02.014_bib0225', 'first-page': '1', 'article-title': 'An update on COVID-19 pandemic: The epidemiology, pathogenesis, ' 'prevention and treatment strategies', 'author': 'Tsang', 'year': '2020', 'journal-title': 'Expert Rev Anti Infect Ther'}, { 'issue': 'May (10234)', 'key': '10.1016/j.ijid.2021.02.014_bib0230', 'doi-asserted-by': 'crossref', 'first-page': '1417', 'DOI': '10.1016/S0140-6736(20)30937-5', 'article-title': 'Endothelial cell infection and endotheliitis in COVID-19', 'volume': '395', 'author': 'Varga', 'year': '2020', 'journal-title': 'Lancet (London, England)'}, { 'key': '10.1016/j.ijid.2021.02.014_bib0235', 'doi-asserted-by': 'crossref', 'first-page': '104950', 'DOI': '10.1016/j.phrs.2020.104950', 'article-title': 'Enhanced platelet inhibition treatment improves hypoxemia in patients ' 'with severe Covid-19 and hypercoagulability. A case control, proof of ' 'concept study', 'volume': '158', 'author': 'Viecca', 'year': '2020', 'journal-title': 'Pharmacol Res'}, { 'issue': 'May (10236)', 'key': '10.1016/j.ijid.2021.02.014_bib0240', 'doi-asserted-by': 'crossref', 'first-page': '1569', 'DOI': '10.1016/S0140-6736(20)31022-9', 'article-title': 'Remdesivir in adults with severe COVID-19: A randomised, double-blind, ' 'placebo-controlled, multicentre trial', 'volume': '395', 'author': 'Wang', 'year': '2020', 'journal-title': 'Lancet (London, England).'}, { 'key': '10.1016/j.ijid.2021.02.014_bib0245', 'series-title': 'Contact Tracing in the Context of COVID-19. WHO Guide', 'first-page': '1', 'author': 'World Health Organization', 'year': '2020'}], 'container-title': 'International Journal of Infectious Diseases', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S1201971221001004?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S1201971221001004?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2021, 8, 4]], 'date-time': '2021-08-04T16:42:00Z', 'timestamp': 1628095320000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S1201971221001004'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 4]]}, 'references-count': 49, 'alternative-id': ['S1201971221001004'], 'URL': 'http://dx.doi.org/10.1016/j.ijid.2021.02.014', 'relation': {'has-review': [{'id-type': 'doi', 'id': '10.32388/27SABJ', 'asserted-by': 'object'}]}, 'ISSN': ['1201-9712'], 'subject': ['Infectious Diseases', 'Microbiology (medical)', 'General Medicine'], 'container-title-short': 'International Journal of Infectious Diseases', 'published': {'date-parts': [[2021, 4]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Effectiveness of a multidrug therapy consisting of Ivermectin, Azithromycin, ' 'Montelukast, and Acetylsalicylic acid to prevent hospitalization and death ' 'among ambulatory COVID-19 cases in Tlaxcala, Mexico', 'name': 'articletitle', 'label': 'Article Title'}, { 'value': 'International Journal of Infectious Diseases', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.ijid.2021.02.014', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2021 The Authors. Published by Elsevier Ltd on behalf of International ' 'Society for Infectious Diseases.', 'name': 'copyright', 'label': 'Copyright'}]}